3 articles
Hangzhou-based BrainCo is developing a wearable that it says could suppress appetite through brain stimulation, founding partner Nyx He told Bloomberg in an interview published on 3 November 2026, and aims to bring it to market within two to three years, starting in China. BrainCo has not named the device, given technical details or published any trial data.
Hangzhou-based Nanochap Electronics said on 3 November 2026 that it had closed a RMB 500 million Series C+ round led by Gaorong Ventures, its second round of 2026, bringing its total funding to RMB 1 billion. The company is running a registration trial of a 320-channel retinal implant that it says has been placed in three blind patients.
State-owned PICC Property and Casualty signed China's first commercial insurance policy covering invasive brain-computer interface surgery on Wednesday 12 August 2026. Counterparty is the Second Affiliated Hospital of Zhejiang University School of Medicine. Zhejiang Provincial Government Office released a same-day industry-policy package. Hong Kong and Shenzhen BCI-tagged stocks rallied.
Get the latest BCI news, breakthroughs, and market moves delivered to your inbox.
No spam. One-click unsubscribe. We respect your privacy.